These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35289971)

  • 1. Selection of O-negative induced pluripotent stem cell clones for high-density red blood cell production in a scalable perfusion bioreactor system.
    Yu S; Vassilev S; Lim ZR; Sivalingam J; Lam ATL; Ho V; Renia L; Malleret B; Reuveny S; Oh SKW
    Cell Prolif; 2022 Aug; 55(8):e13218. PubMed ID: 35289971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Scalable Suspension Platform for Generating High-Density Cultures of Universal Red Blood Cells from Human Induced Pluripotent Stem Cells.
    Sivalingam J; SuE Y; Lim ZR; Lam ATL; Lee AP; Lim HL; Chen HY; Tan HK; Warrier T; Hang JW; Nazir NB; Tan AHM; Renia L; Loh YH; Reuveny S; Malleret B; Oh SKW
    Stem Cell Reports; 2021 Jan; 16(1):182-197. PubMed ID: 33306988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources.
    Cho YK; Kim HK; Kwon SS; Jeon SH; Cheong JW; Nam KT; Kim HS; Kim S; Kim HO
    Stem Cell Res Ther; 2023 Apr; 14(1):106. PubMed ID: 37101221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors.
    Gallego-Murillo JS; Iacono G; van der Wielen LAM; van den Akker E; von Lindern M; Wahl SA
    Biotechnol Bioeng; 2022 Nov; 119(11):3096-3116. PubMed ID: 35879812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins.
    Yang CT; French A; Goh PA; Pagnamenta A; Mettananda S; Taylor J; Knight S; Nathwani A; Roberts DJ; Watt SM; Carpenter L
    Br J Haematol; 2014 Aug; 166(3):435-48. PubMed ID: 24837254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Red Blood Cells from Human Pluripotent Stem Cells-An Update.
    Lee SJ; Jung C; Oh JE; Kim S; Lee S; Lee JY; Yoon YS
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of red blood cells from human induced pluripotent stem cells.
    Dias J; Gumenyuk M; Kang H; Vodyanik M; Yu J; Thomson JA; Slukvin II
    Stem Cells Dev; 2011 Sep; 20(9):1639-47. PubMed ID: 21434814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industrially Compatible Transfusable iPSC-Derived RBCs: Progress, Challenges and Prospective Solutions.
    Lim ZR; Vassilev S; Leong YW; Hang JW; Rénia L; Malleret B; Oh SK
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell generation by three-dimensional aggregate cultivation of late erythroblasts.
    Lee E; Han SY; Choi HS; Chun B; Hwang B; Baek EJ
    Tissue Eng Part A; 2015 Feb; 21(3-4):817-28. PubMed ID: 25314917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells.
    Ju H; Sohn Y; Nam Y; Rim YA
    Stem Cell Res Ther; 2024 May; 15(1):142. PubMed ID: 38750578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor.
    Laco F; Lam AT; Woo TL; Tong G; Ho V; Soong PL; Grishina E; Lin KH; Reuveny S; Oh SK
    Stem Cell Res Ther; 2020 Mar; 11(1):118. PubMed ID: 32183888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmental hollow fiber capillary membrane-based bioreactor technology for in vitro studies on red blood cell lineage direction of hematopoietic stem cells.
    Housler GJ; Miki T; Schmelzer E; Pekor C; Zhang X; Kang L; Voskinarian-Berse V; Abbot S; Zeilinger K; Gerlach JC
    Tissue Eng Part C Methods; 2012 Feb; 18(2):133-42. PubMed ID: 21933020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors.
    Borys BS; Dang T; So T; Rohani L; Revay T; Walsh T; Thompson M; Argiropoulos B; Rancourt DE; Jung S; Hashimura Y; Lee B; Kallos MS
    Stem Cell Res Ther; 2021 Jan; 12(1):55. PubMed ID: 33436078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors.
    Merryweather-Clarke AT; Tipping AJ; Lamikanra AA; Fa R; Abu-Jamous B; Tsang HP; Carpenter L; Robson KJ; Nandi AK; Roberts DJ
    BMC Genomics; 2016 Oct; 17(1):817. PubMed ID: 27769165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red cell manufacturing using parallel stirred-tank bioreactors at the final stages of differentiation enhances reticulocyte maturation.
    Han SY; Lee EM; Lee J; Lee H; Kwon AM; Ryu KY; Choi WS; Baek EJ
    Biotechnol Bioeng; 2021 May; 118(5):1763-1778. PubMed ID: 33491764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROTAC-mediated vimentin degradation promotes terminal erythroid differentiation of pluripotent stem cells.
    Yan H; Zang R; Cui T; Liu Y; Zhang B; Zhao L; Li H; Zhou J; Wang H; Zeng Q; Xu L; Zhou Y; Pei X; Xi J; Yue W
    Stem Cell Res Ther; 2024 Sep; 15(1):310. PubMed ID: 39294765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells.
    Pavani G; Klein JG; Nations CC; Sussman JH; Tan K; An HH; Abdulmalik O; Thom CS; Gearhart PA; Willett CM; Maguire JA; Chou ST; French DL; Gadue P
    Blood Adv; 2024 Mar; 8(6):1449-1463. PubMed ID: 38290102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular roadmap of definitive erythropoiesis from human induced pluripotent stem cells.
    Razaq MA; Taylor S; Roberts DJ; Carpenter L
    Br J Haematol; 2017 Mar; 176(6):971-983. PubMed ID: 28060419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Human Induced Pluripotent Stem Cell Expansion in Stirred-Suspension Culture.
    Meng G; Liu S; Poon A; Rancourt DE
    Stem Cells Dev; 2017 Dec; 26(24):1804-1817. PubMed ID: 29017378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel perfusion bioreactor promotes the expansion of pluripotent stem cells in a 3D-bioprinted tissue chamber.
    Komosa ER; Lin WH; Mahadik B; Bazzi MS; Townsend D; Fisher JP; Ogle BM
    Biofabrication; 2023 Nov; 16(1):. PubMed ID: 37906964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.